Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 USD | -5.63% |
|
-4.75% | -37.34% |
Jun. 12 | Cytek Biosciences to Seek M&A | CI |
Jun. 12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.34% | 793M | |
+9.96% | 189B | |
+26.10% | 150B | |
+33.13% | 113B | |
+1.98% | 65.05B | |
+14.64% | 52.83B | |
+2.92% | 49.39B | |
-6.42% | 38.1B | |
-2.11% | 35.14B | |
+23.17% | 31.2B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Stephens Initiates Cytek Biosciences With Overweight Rating, Price Target is $9